» Articles » PMID: 37228653

Role of MiR-182 in Cardiovascular and Cerebrovascular Diseases

Overview
Specialty Cell Biology
Date 2023 May 25
PMID 37228653
Authors
Affiliations
Soon will be listed here.
Abstract

The treatment of cardiovascular and cerebrovascular diseases have undergone major advances in recent decades, allowing for a more effective prevention of cardiovascular and cerebrovascular events. However, cardiac and cerebral atherothrombotic complications still account for substantial morbidity and mortality worldwide. Novel therapeutic strategies are critical to improve patient outcomes following cardiovascular diseases. miRNAs are small non-coding RNAs, that regulate gene expression. Here, we discuss the role of miR-182 in regulating myocardial proliferation, migration, hypoxia, ischemia, apoptosis and hypertrophy in atherosclerosis, CAD, MI, I/R injury, organ transplant, cardiac hypertrophy, hypertension, heart failure, congenital heart disease and cardiotoxicity. Besides, we also summarize the current progress of miR-182 therapeutics in clinical development and discuss challenges that will need to be overcome to enter the clinic for patients with cardiac disease.

Citing Articles

Emerging biologic and clinical implications of miR-182-5p in gynecologic cancers.

Zehtabi M, Ghaedrahmati F, Gale Dari M, Moramezi F, Kempisty B, Mozdziak P Clin Transl Oncol. 2024; .

PMID: 39661239 DOI: 10.1007/s12094-024-03822-9.


Effect of miR-182-5p on apoptosis in myocardial infarction.

Niu N, Miao H, Ren H Heliyon. 2023; 9(11):e21524.

PMID: 38034598 PMC: 10685254. DOI: 10.1016/j.heliyon.2023.e21524.

References
1.
Xu S, Witmer P, Lumayag S, Kovacs B, Valle D . MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J Biol Chem. 2007; 282(34):25053-66. DOI: 10.1074/jbc.M700501200. View

2.
Sun L, Bai Y, Zhao R, Sun T, Cao R, Wang F . Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients. Arterioscler Thromb Vasc Biol. 2016; 36(7):1386-97. DOI: 10.1161/ATVBAHA.115.307412. View

3.
Beermann J, Piccoli M, Viereck J, Thum T . Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiol Rev. 2016; 96(4):1297-325. DOI: 10.1152/physrev.00041.2015. View

4.
Chen Y, Xue J, Fang D, Tian X . Clinical Value and Mechanism of Long Non-Coding RNA UCA1 in Acute Respiratory Distress Syndrome Induced by Cardiopulmonary Bypass. Heart Lung Circ. 2022; 32(4):544-551. PMC: 9709611. DOI: 10.1016/j.hlc.2022.10.008. View

5.
Kim K, Park S, Jung S, Kim E, Jogeswar G, Ajita J . miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1. J Bone Miner Res. 2012; 27(8):1669-79. DOI: 10.1002/jbmr.1604. View